Arthritis Remedies http://www.remediesarthritis.com All About Arthritis And Arthritis Treatment Thu, 11 Mar 2010 18:21:00 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 Roche, Biogen suspend arthritis drug after deaths (Reuters via Yahoo! News) http://www.remediesarthritis.com/roche-biogen-suspend-arthritis-drug-after-deaths-reuters-via-yahoo-news.html http://www.remediesarthritis.com/roche-biogen-suspend-arthritis-drug-after-deaths-reuters-via-yahoo-news.html#comments Thu, 11 Mar 2010 18:21:00 +0000 Arthritis Expert http://www.remediesarthritis.com/roche-biogen-suspend-arthritis-drug-after-deaths-reuters-via-yahoo-news.html Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending rheumatoid arthritis and lupus treatment ocrelizumab after it caused deaths, casting doubt over the drug’s future. …

See more here:
Roche, Biogen suspend arthritis drug after deaths (Reuters via Yahoo! News)

]]> http://www.remediesarthritis.com/roche-biogen-suspend-arthritis-drug-after-deaths-reuters-via-yahoo-news.html/feed 0 Medical Seminar "Arthritis Pain Treatment" Part 3 http://www.remediesarthritis.com/medical-seminar-arthritis-pain-treatment-part-3.html http://www.remediesarthritis.com/medical-seminar-arthritis-pain-treatment-part-3.html#comments Thu, 11 Mar 2010 15:09:40 +0000 Arthritis Expert http://www.remediesarthritis.com/medical-seminar-arthritis-pain-treatment-part-3.html http://www.youtube.com/v/5iUYxYvViLI?f=videos&app=youtube_gdata

]]> http://www.remediesarthritis.com/medical-seminar-arthritis-pain-treatment-part-3.html/feed 0 Roche, Biogen Idec to suspend Ocrelizumab treatment of patients in RA programme (PharmaBiz) http://www.remediesarthritis.com/roche-biogen-idec-to-suspend-ocrelizumab-treatment-of-patients-in-ra-programme-pharmabiz.html http://www.remediesarthritis.com/roche-biogen-idec-to-suspend-ocrelizumab-treatment-of-patients-in-ra-programme-pharmabiz.html#comments Wed, 10 Mar 2010 18:59:52 +0000 Arthritis Expert http://www.remediesarthritis.com/roche-biogen-idec-to-suspend-ocrelizumab-treatment-of-patients-in-ra-programme-pharmabiz.html Roche and Biogen Idec announced their decision to suspend Ocrelizumab treatment of patients in the Rheumatoid Arthritis (RA) programme. …

Read more:
Roche, Biogen Idec to suspend Ocrelizumab treatment of patients in RA programme (PharmaBiz)

]]> http://www.remediesarthritis.com/roche-biogen-idec-to-suspend-ocrelizumab-treatment-of-patients-in-ra-programme-pharmabiz.html/feed 0 Study finds sizeable position for Actemra in rheumatoid arthritis treatment paradigm (News-Medical-Net) http://www.remediesarthritis.com/study-finds-sizeable-position-for-actemra-in-rheumatoid-arthritis-treatment-paradigm-news-medical-net.html http://www.remediesarthritis.com/study-finds-sizeable-position-for-actemra-in-rheumatoid-arthritis-treatment-paradigm-news-medical-net.html#comments Wed, 10 Mar 2010 04:25:50 +0000 Arthritis Expert http://www.remediesarthritis.com/study-finds-sizeable-position-for-actemra-in-rheumatoid-arthritis-treatment-paradigm-news-medical-net.html Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb’s Orencia, Johnson & Johnson’s Remicade, and Amgen’s/Wyeth’s Enbrel will forfeit share of the rheumatoid arthritis market to Roche’s newly launched Actemra. Early switching data from Majestics proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to … …

See the rest here:
Study finds sizeable position for Actemra in rheumatoid arthritis treatment paradigm (News-Medical-Net)

]]> http://www.remediesarthritis.com/study-finds-sizeable-position-for-actemra-in-rheumatoid-arthritis-treatment-paradigm-news-medical-net.html/feed 0 Roche And Biogen Idec Decide To Suspend Ocrelizumab Treatment – Rheumatoid Arthritis Development Programme On Hold (PharmaceuticalOnline) http://www.remediesarthritis.com/roche-and-biogen-idec-decide-to-suspend-ocrelizumab-treatment-rheumatoid-arthritis-development-programme-on-hold-pharmaceuticalonline.html http://www.remediesarthritis.com/roche-and-biogen-idec-decide-to-suspend-ocrelizumab-treatment-rheumatoid-arthritis-development-programme-on-hold-pharmaceuticalonline.html#comments Tue, 09 Mar 2010 11:04:43 +0000 Arthritis Expert http://www.remediesarthritis.com/roche-and-biogen-idec-decide-to-suspend-ocrelizumab-treatment-rheumatoid-arthritis-development-programme-on-hold-pharmaceuticalonline.html Roche and Biogen Idec announced recently their decision to suspend Ocrelizumab treatment of patients in the Rheumatoid Arthritis (RA) programme. …

Read more from the original source:
Roche And Biogen Idec Decide To Suspend Ocrelizumab Treatment – Rheumatoid Arthritis Development Programme On Hold (PharmaceuticalOnline)

]]> http://www.remediesarthritis.com/roche-and-biogen-idec-decide-to-suspend-ocrelizumab-treatment-rheumatoid-arthritis-development-programme-on-hold-pharmaceuticalonline.html/feed 0 Roche, Biogen suspends arthritis drug after deaths (Reuters via Yahoo! News) http://www.remediesarthritis.com/roche-biogen-suspends-arthritis-drug-after-deaths-reuters-via-yahoo-news.html http://www.remediesarthritis.com/roche-biogen-suspends-arthritis-drug-after-deaths-reuters-via-yahoo-news.html#comments Mon, 08 Mar 2010 17:43:47 +0000 Arthritis Expert http://www.remediesarthritis.com/roche-biogen-suspends-arthritis-drug-after-deaths-reuters-via-yahoo-news.html Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future. …

Follow this link:
Roche, Biogen suspends arthritis drug after deaths (Reuters via Yahoo! News)

]]> http://www.remediesarthritis.com/roche-biogen-suspends-arthritis-drug-after-deaths-reuters-via-yahoo-news.html/feed 0 Launch By Menarini And Ipsen Of ADENURIC(R) (febuxostat) In France For The Treatment Of Chronic Hyperuricemia In Gout (Medical News Today) http://www.remediesarthritis.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout-medical-news-today.html http://www.remediesarthritis.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout-medical-news-today.html#comments Sun, 07 Mar 2010 23:06:10 +0000 Arthritis Expert http://www.remediesarthritis.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout-medical-news-today.html Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group and Menarini, the first Italian pharmaceutical Group in the world with a significant pan-European presence, announced the launch of ADENURIC (febuxostat) in France where they will co-promote the drug. Other launches by Menarini are planned shortly, notably in United Kingdom, Germany and Ireland. Thierry … …

Go here to see the original:
Launch By Menarini And Ipsen Of ADENURIC(R) (febuxostat) In France For The Treatment Of Chronic Hyperuricemia In Gout (Medical News Today)

]]> http://www.remediesarthritis.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout-medical-news-today.html/feed 0 Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis (News-Medical-Net) http://www.remediesarthritis.com/peptimmune-granted-us-patent-for-pi-2301-peptide-copolymer-in-treatment-of-multiple-sclerosis-news-medical-net.html http://www.remediesarthritis.com/peptimmune-granted-us-patent-for-pi-2301-peptide-copolymer-in-treatment-of-multiple-sclerosis-news-medical-net.html#comments Sun, 07 Mar 2010 03:51:33 +0000 Arthritis Expert http://www.remediesarthritis.com/peptimmune-granted-us-patent-for-pi-2301-peptide-copolymer-in-treatment-of-multiple-sclerosis-news-medical-net.html Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the ‘221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases. …

Read more from the original source:
Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis (News-Medical-Net)

]]> http://www.remediesarthritis.com/peptimmune-granted-us-patent-for-pi-2301-peptide-copolymer-in-treatment-of-multiple-sclerosis-news-medical-net.html/feed 0 Arthritis affects children, not just seniors (Kitchener – Waterloo Record) http://www.remediesarthritis.com/arthritis-affects-children-not-just-seniors-kitchener-waterloo-record.html http://www.remediesarthritis.com/arthritis-affects-children-not-just-seniors-kitchener-waterloo-record.html#comments Sat, 06 Mar 2010 11:38:55 +0000 Arthritis Expert http://www.remediesarthritis.com/arthritis-affects-children-not-just-seniors-kitchener-waterloo-record.html Michelle and Tim Banic understand when people think that only elderly people get arthritis. …

View post:
Arthritis affects children, not just seniors (Kitchener – Waterloo Record)

]]> http://www.remediesarthritis.com/arthritis-affects-children-not-just-seniors-kitchener-waterloo-record.html/feed 0 NICE Asks For More Data On New Drug For Rheumatoid Arthritis (Medical News Today) http://www.remediesarthritis.com/nice-asks-for-more-data-on-new-drug-for-rheumatoid-arthritis-medical-news-today.html http://www.remediesarthritis.com/nice-asks-for-more-data-on-new-drug-for-rheumatoid-arthritis-medical-news-today.html#comments Fri, 05 Mar 2010 16:33:19 +0000 Arthritis Expert http://www.remediesarthritis.com/nice-asks-for-more-data-on-new-drug-for-rheumatoid-arthritis-medical-news-today.html NICE’s independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product. The committee is minded not to recommend the use of the drug but the additional information it has asked for today (4 March) could result in the final guidance being positive at … …

More here:
NICE Asks For More Data On New Drug For Rheumatoid Arthritis (Medical News Today)

]]> http://www.remediesarthritis.com/nice-asks-for-more-data-on-new-drug-for-rheumatoid-arthritis-medical-news-today.html/feed 0